Global Surveillance of Emerging Influenza Virus Genotypes by Mass Spectrometry
Rangarajan Sampath(Analytical Services), David J. Ecker(University of Colorado Denver), Amy Schink(Ionis Pharmaceuticals (United States)), Samuel Yang(Palo Alto University), Jared J. Drader(Naval Health Research Center), Richard E. Rothman(Rush University Medical Center), Brian Libby(Naval Health Research Center), Jose R. Gutierrez(Ionis Pharmaceuticals (United States)), Karl Rudnick(Naval Health Research Center), Rachael Melton(Naval Health Research Center), Marshall R. Monteville(Naval Medical Research Command), Stanley M. Lemon(Bipar), Lawrence B. Blyn(Ionis Pharmaceuticals (United States)), David E. Stallknecht(University of Georgia), Steven A. Hofstadler(Analytical Services), Carson Baldwin(United States Army Medical Research Institute of Infectious Diseases), Kirsten St. George(New York State Department of Health), Raymond Ranken(Ionis Pharmaceuticals (United States)), Ginger Goekjian(University of Georgia), Christian Massire(Ionis Pharmaceuticals (United States)), Cristina Ivy(Naval Health Research Center), Nancy Fan(Ionis Pharmaceuticals (United States)), Charlotte A. Gaydos(Johns Hopkins University), David Moore(University College Hospital), Michael Pear(Ionis Pharmaceuticals (United States)), Demetrius J. Walcott(Ionis Pharmaceuticals (United States)), Thomas A. Hall(Ionis Pharmaceuticals (United States)), Amy B. Dean(University of Victoria), Meghan Fuschino(New York State Department of Health), David Metzgar(Ionis Pharmaceuticals (United States)), Samuel Yingst(Naval Medical Research Unit EURAFCENT), Feng Li(MEP Equine Solutions (United States)), Chris A. Whitehouse(United States Army Medical Research Institute of Infectious Diseases), Kevin L. Russell(Armed Forces Health Surveillance Center), Harold Levene(Ionis Pharmaceuticals (United States)), Magdi D. Saad(Naval Medical Research Unit EURAFCENT), Mark W. Eshoo(Ionis Pharmaceuticals (United States)), Lynda Addington(Naval Health Research Center), Thuy Pennella(Ionis Pharmaceuticals (United States)), Vanessa Harpin(Ionis Pharmaceuticals (United States))
Cited by 128
Related Papers
Antigenic and Genetic Characteristics of Swine-Origin 2009 A(H1N1) Influenza Viruses Circulating in Humans
|Science|2009|2.5k
miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting
|Cell Metabolism|2006|2.1k
A Multiubiquitin Chain Is Confined to Specific Lysine in a Targeted Short-Lived Protein
|Science|1989|1.5k
EUROPAEM EMF Guideline 2016 for the prevention, diagnosis and treatment of EMF-related health problems and illnesses
|Reviews on Environmental Health|2016|496
Analysis of Antibiotic Resistance Genes in Multidrug-Resistant <i>Acinetobacter</i> sp. Isolates from Military and Civilian Patients Treated at the Walter Reed Army Medical Center
|Antimicrobial Agents and Chemotherapy|2006|481